September 18, 2020 Comments Off on New patent for Boehringer Ingelheim drug OFEV Posted in: Patent Added Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Boehringer Ingelheim drug OFEV appeared first on Drug…
September 18, 2020 Comments Off on New patent expiration for Acorda drug INBRIJA Posted in: Uncategorized
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are eighteen patents protecting…
The post New patent expiration for Acorda drug INBRIJA appeared first …
